CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043321804
- Phone
- (608) 441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-08 | Loren Stefan Consultant | Grant or award · Stock option (right to buy) | +15,000 | 15,000 | ||
| 2026-07-08 | Loren Stefan Consultant | Grant or award · Stock option (right to buy) | +15,000 | 15,000 | ||
| 2026-07-07 | Kolean Chad J CFO | Grant or award · Stock option (right to buy) | +92,000 | 92,000 | ||
| 2026-07-07 | DRISCOLL FREDERICK W Director | Grant or award · Stock option (right to buy) | +25,000 | 25,000 | ||
| 2026-07-07 | Chanan-Khan Asher Director | Grant or award · Stock option (right to buy) | +25,000 | 25,000 | ||
| 2026-07-07 | CARUSO JAMES V President & CEO | Grant or award · Stock option (right to buy) | +250,000 | 250,000 | ||
| 2026-07-07 | Gu Andrew Director | Grant or award · Stock option (right to buy) | +25,000 | 25,000 | ||
| 2026-07-07 | Longcor Jarrod Chief Operating Officer | Grant or award · Stock option (right to buy) | +118,000 | 118,000 | ||
| 2026-07-07 | Swirsky Douglas J Director | Grant or award · Stock option (right to buy) | +37,500 | 37,500 | ||
| 2026-07-07 | NEIS JOHN Director | Grant or award · Stock option (right to buy) | +25,000 | 25,000 | ||
| 2026-05-07 | Longcor Jarrod Chief Operating Officer | Purchase | +8,680 | $2.88 | $25K | 20,451 |
| 2026-05-07 | Longcor Jarrod Chief Operating Officer | Purchase · Warrants | +26,040 | $0.01 | $260 | 36,149 |
| 2026-05-07 | CARUSO JAMES V Chief Executive Officer | Purchase | +8,680 | $2.88 | $25K | 20,318 |
| 2026-05-07 | CARUSO JAMES V Chief Executive Officer | Purchase · Warrants | +26,040 | $0.01 | $260 | 36,076 |
| 2025-12-12 | NEIS JOHN Director | Sale | −198 | $3.70 | $732 | 10 |
| 2025-07-02 | CARUSO JAMES V Chief Executive Officer | Purchase | +10,000 | $4.99 | $50K | 11,638 |
| 2025-07-02 | CARUSO JAMES V Chief Executive Officer | Purchase · Warrants | +10,000 | $0.01 | $100 | 10,000 |
| 2025-07-02 | Longcor Jarrod Chief Operating Officer | Purchase | +10,000 | $4.99 | $50K | 12,768 |
| 2025-07-02 | Longcor Jarrod Chief Operating Officer | Purchase · Warrants | +10,000 | $0.01 | $100 | 10,000 |
| 2025-07-02 | Kolean Chad J Chief Financial Officer | Purchase | +5,000 | $4.99 | $25K | 6,418 |
Page 1 of 6 · 117 trades